The publication library
Explore every topic
Follow a question from the overview to the evidence, limitations and practical tools.
Perimenopause
Menopause
Strength & Performance
Metabolic Health
Hormones & Treatments
Supplements
GLP-1
Skin & Hair
Sleep & Stress
Peptides & Emerging Therapies
- BPC-157: Human Evidence, Safety, and Regulatory Reality
- CJC-1295 and Ipamorelin: Claims, Evidence, and Safety Gaps
- FDA-Approved, Compounded, Investigational, or Research-Market Peptides
- GHK-Cu Evidence: Topical Cosmetics Are Not Injectable Therapy
- Gray-Market Peptide Intelligence
- How to Read a Peptide Certificate of Analysis
- How to Read a Peptide Clinical Trial
- Ipamorelin Evidence: Benefits, Side Effects, and Regulatory Status
- MOTS-c: What Human Evidence Exists?
- Peptide Safety: What the Label Does Not Tell You
- Peptides for Women Over 40: A Goal-by-Goal Evidence Map
- Purity Is Not Sterility: Peptide Testing Explained
- TB-500 Evidence: Human Data, Safety, and Marketing Claims
- TFB Vendor Transparency Methodology
- What “Research Use Only” Means on Peptides